O, C., CF, B., M, P., & A, S. (2021). Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome. Clinical pharmacology and therapeutics, 110(2), 311. https://doi.org/10.1002/cpt.2183
Chicago Style (17th ed.) CitationO, Collignon, Burman CF, Posch M, and Schiel A. "Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome." Clinical Pharmacology and Therapeutics 110, no. 2 (2021): 311. https://doi.org/10.1002/cpt.2183.
MLA (9th ed.) CitationO, Collignon, et al. "Collaborative Platform Trials to Fight COVID-19: Methodological and Regulatory Considerations for a Better Societal Outcome." Clinical Pharmacology and Therapeutics, vol. 110, no. 2, 2021, p. 311, https://doi.org/10.1002/cpt.2183.